U.S. FDA authorizes Pfizer's COVID-19 booster for 12- to 15-year-olds

On Monday January 3rd, the U.S. Food and Drug Administration authorized the use of a third dose of the Pfizer COVID-19 vaccine for children ages 12 to 15.